Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial

Authors

Institutions

Publication Details

Journal
JMIR Research Protocols
Published
2025-05-29
DOI
https://doi.org/10.2196/72549
Citations
1
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial

Jun Saegusa, Toshiyasu Sakane, Kotaro Itohara, Kazuhiro Yamamoto et al.
1 citations
JMIR Research Protocols
Cytomegalovirus and herpesvirus research
1.35
article

Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial

Jun Saegusa, Toshiyasu Sakane, Kotaro Itohara, Kazuhiro Yamamoto, Naoki Tamura, Tomohiro Omura, Yumi Kitahiro, Ikuko Yano, Yo Ueda
article en
1 citations

Abstract

No abstract available for this paper.
JMIR Research ProtocolsVol. 14
Okayama University (JP), Kobe Pharmaceutical University (JP), Kobe University Hospital (JP), Kobe University (JP)
Good health and well-being
Openalex Percentile: Top 19%
Cytomegalovirus and herpesvirus research
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial — Jun Saegusa, Toshiyasu Sakane, et al. · JMIR Research Protocols (2025) | TGRS Research Map | TGRS